Recall Radar
All recallsMedicine & devices

GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91.

Presence of particulate matter

Class II Medicine & devices FDA April 15, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
GE Healthcare Ireland Limited — Carrigtwohill
Severity
Class II — moderate
Reported
April 15, 2026
Quantity
306,810 vials
Recall number
D-0448-2026
Status
Ongoing
Source
FDA

Where it went

U.S. Nationwide.

Other medicine & devices recalls

See every current recall on the live dashboard →